adesso Future Growth
Future criteria checks 4/6
adesso is forecast to grow earnings and revenue by 46.4% and 11.7% per annum respectively. EPS is expected to grow by 45.6% per annum. Return on equity is forecast to be 11.8% in 3 years.
Key information
46.4%
Earnings growth rate
45.6%
EPS growth rate
IT earnings growth | 15.2% |
Revenue growth rate | 11.7% |
Future return on equity | 11.8% |
Analyst coverage | Good |
Last updated | 02 Sep 2024 |
Recent future growth updates
Recent updates
It's Down 25% But adesso SE (ETR:ADN1) Could Be Riskier Than It Looks
Aug 28adesso's (ETR:ADN1) Shareholders Will Receive A Bigger Dividend Than Last Year
May 21adesso (ETR:ADN1) Has Announced That It Will Be Increasing Its Dividend To €0.70
Apr 19Returns On Capital Signal Tricky Times Ahead For adesso (ETR:ADN1)
Apr 18Investors Can Find Comfort In adesso's (ETR:ADN1) Earnings Quality
Apr 02Analysts Are Updating Their adesso SE (ETR:ADN1) Estimates After Its Annual Results
Mar 28Is adesso SE (ETR:ADN1) Trading At A 44% Discount?
Mar 23adesso SE (ETR:ADN1) Soars 29% But It's A Story Of Risk Vs Reward
Mar 08A Look At The Intrinsic Value Of adesso SE (ETR:ADN1)
Dec 14Does adesso (ETR:ADN1) Have A Healthy Balance Sheet?
Oct 11At €106, Is It Time To Put adesso SE (ETR:ADN1) On Your Watch List?
Jul 22Calculating The Intrinsic Value Of adesso SE (ETR:ADN1)
Jun 15adesso's (ETR:ADN1) Returns On Capital Not Reflecting Well On The Business
May 09What Does adesso SE's (ETR:ADN1) Share Price Indicate?
Apr 22adesso (ETR:ADN1) Has A Pretty Healthy Balance Sheet
Feb 11Returns On Capital At adesso (ETR:ADN1) Have Stalled
Jan 26Calculating The Fair Value Of adesso SE (ETR:ADN1)
Jan 10At €138, Is It Time To Put adesso SE (ETR:ADN1) On Your Watch List?
Dec 14We Think adesso (ETR:ADN1) Can Stay On Top Of Its Debt
Aug 22Why adesso SE (ETR:ADN1) Could Be Worth Watching
Aug 07adesso (ETR:ADN1) Hasn't Managed To Accelerate Its Returns
Jul 21Is adesso (ETR:ADN1) A Risky Investment?
May 12Is It Too Late To Consider Buying adesso SE (ETR:ADN1)?
Apr 29adesso (ETR:ADN1) Might Be Having Difficulty Using Its Capital Effectively
Apr 12Should You Be Adding adesso (ETR:ADN1) To Your Watchlist Today?
Mar 29Is There Now An Opportunity In adesso SE (ETR:ADN1)?
Jan 13I Ran A Stock Scan For Earnings Growth And adesso (ETR:ADN1) Passed With Ease
Dec 27adesso (ETR:ADN1) Has A Pretty Healthy Balance Sheet
Oct 16Why adesso SE (ETR:ADN1) Could Be Worth Watching
Sep 28Do adesso's (ETR:ADN1) Earnings Warrant Your Attention?
Aug 23The Returns At adesso (ETR:ADN1) Aren't Growing
Jul 07Calculating The Fair Value Of adesso SE (ETR:ADN1)
Jun 15When Should You Buy adesso SE (ETR:ADN1)?
Jun 02Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,643 | 37 | 39 | 95 | 6 |
12/31/2025 | 1,471 | 26 | 27 | 79 | 6 |
12/31/2024 | 1,307 | 10 | 8 | 63 | 6 |
6/30/2024 | 1,225 | -1 | 94 | 129 | N/A |
3/31/2024 | 1,182 | -2 | 51 | 83 | N/A |
12/31/2023 | 1,140 | 3 | 43 | 77 | N/A |
9/30/2023 | 1,084 | 5 | -23 | 7 | N/A |
6/30/2023 | 1,037 | 12 | -28 | -1 | N/A |
3/31/2023 | 969 | 18 | 7 | 35 | N/A |
12/31/2022 | 901 | 29 | 12 | 36 | N/A |
9/30/2022 | 836 | 29 | 12 | 36 | N/A |
6/30/2022 | 769 | 28 | 12 | 33 | N/A |
3/31/2022 | 725 | 37 | 17 | 36 | N/A |
12/31/2021 | 678 | 48 | 30 | 48 | N/A |
9/30/2021 | 636 | 45 | 23 | 43 | N/A |
6/30/2021 | 600 | 46 | 23 | 37 | N/A |
3/31/2021 | 564 | 42 | 34 | 47 | N/A |
12/31/2020 | 524 | 21 | 54 | 65 | N/A |
9/30/2020 | 503 | 24 | 34 | 40 | N/A |
6/30/2020 | 484 | 19 | 34 | 43 | N/A |
3/31/2020 | 467 | 18 | 22 | 33 | N/A |
12/31/2019 | 451 | 17 | 11 | 22 | N/A |
9/30/2019 | 432 | 15 | 1 | 13 | N/A |
6/30/2019 | 412 | 13 | -9 | 3 | N/A |
3/31/2019 | 395 | 13 | 0 | 10 | N/A |
12/31/2018 | 378 | 14 | 9 | 18 | N/A |
9/30/2018 | 364 | 14 | 14 | 22 | N/A |
6/30/2018 | 351 | 14 | 20 | 26 | N/A |
3/31/2018 | 336 | 13 | N/A | 23 | N/A |
12/31/2017 | 322 | 11 | N/A | 20 | N/A |
9/30/2017 | 307 | 11 | N/A | 17 | N/A |
6/30/2017 | 292 | 11 | N/A | 13 | N/A |
3/31/2017 | 276 | 12 | N/A | 14 | N/A |
12/31/2016 | 261 | 12 | N/A | 15 | N/A |
9/30/2016 | 245 | 10 | N/A | 14 | N/A |
6/30/2016 | 229 | 7 | N/A | 14 | N/A |
3/31/2016 | 213 | 6 | N/A | 15 | N/A |
12/31/2015 | 197 | 5 | N/A | 17 | N/A |
9/30/2015 | 183 | 4 | N/A | 17 | N/A |
6/30/2015 | 169 | 4 | N/A | 16 | N/A |
3/31/2015 | 163 | 4 | N/A | 13 | N/A |
12/31/2014 | 157 | 3 | N/A | 9 | N/A |
9/30/2014 | 151 | 3 | N/A | 7 | N/A |
6/30/2014 | 145 | 2 | N/A | 5 | N/A |
3/31/2014 | 140 | 3 | N/A | 7 | N/A |
12/31/2013 | 135 | 3 | N/A | 8 | N/A |
9/30/2013 | 132 | 4 | N/A | 6 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ADN1 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.8%).
Earnings vs Market: ADN1 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ADN1 is expected to become profitable in the next 3 years.
Revenue vs Market: ADN1's revenue (11.7% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: ADN1's revenue (11.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ADN1's Return on Equity is forecast to be low in 3 years time (11.8%).